Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Value-Based Care
Value-Based Care
Next-Generation Sequencing More Cost-Effective and Faster Than Single-Gene Testing
Phoebe Starr
Read More
Value-Based Care
Value-Based Perspectives on the Management of Allergic Rhinitis
Eli O. Meltzer, MD
,
Don A. Bukstein, MD
,
Paul M. Hamrah, MS, PharmD
,
Nikkia Scott, PharmD
,
John A. Welz, MPH
Read More
Value-Based Care
Overcoming Barriers to Cost Transparency in Cancer Care
Chase Doyle
Read More
Value-Based Care
Novel Cancer Drugs Must Adopt Value-Based Pricing
Chase Doyle
Read More
Value-Based Care
Proactive Symptom Self-Reporting Extends Survival in Patients with Metastatic Cancer
Phoebe Starr
Read More
Value-Based Care
Patients with Curable Cancer Experience Significant Symptom Burden and Hospitalization
Chase Doyle
Read More
Value-Based Care
Oncologists Must Begin to Discuss Financial Toxicity with Patients
Chase Doyle
Read More
Value-Based Care
BEACOPP Regimen Superior to ABVD in Newly Diagnosed, Advanced Hodgkin Lymphoma
Chase Doyle
Read More
Value-Based Care
Increased Utilization of Biosimilars in Oncology Could Save Payers Millions
Chase Doyle
Read More
Value-Based Care
Value Frameworks Unreliable in Assessing Novel Hematologic Therapies
Chase Doyle
Read More
1
2
3
4
Page 3 of 4
Results 21 - 30 of 34